Spots Global Cancer Trial Database for gene expression profiling
Every month we try and update this database with for gene expression profiling cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study. | NCT04882475 | Mantle Cell Lym... | 18 Years - 80 Years | Fondazione Italiana Linfomi - ETS | ||
| Gene Expression Profile of Breast Cancer Samples After Vitamin D Supplementation | NCT00926315 | Breast Neoplasm... Postmenopausal ... | calcitriol Calcitriol | 40 Years - 70 Years | University of Sao Paulo General Hospital | |
| Validation of a Personalised Medicine Tool for Multiple Myeloma That Predicts Treatment Effectiveness in Patients | NCT03409692 | Multiple Myelom... | Gene Expression... | 18 Years - | University of Turin, Italy | |
| Microdose Study of Melphalan, Bortezomib and Dexamethasone | NCT02109861 | Multiple Myelom... | Melphalan Bortezomib Dexamethasone | 18 Years - | Aalborg University Hospital | |
| A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area | NCT00913757 | Carcinoma, Hepa... Liver Cirrhosis... Hepatitis, Alco... Hepatitis, Chro... Hepatitis, Vira... | 18 Years - 90 Years | National Institutes of Health Clinical Center (CC) | ||
| UCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell Lymphomas | NCT00082017 | Lymphoma, Large... Lymphoma, T-Cel... | UCN-01 (7-hydro... | 12 Years - | National Institutes of Health Clinical Center (CC) | |
| Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy | NCT01198301 | Breast Neoplasm... Neoplasm Metast... | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | ||
| Sunitinib or Cediranib for Alveolar Soft Part Sarcoma | NCT01391962 | Sarcoma, Alveol... | Cediranib Sunitinib | 16 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion | NCT01256801 | Breast Neoplasm... Neoplasm Metast... Gene Expression... Immunotherapy | cytokine | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | |
| The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer | NCT01310062 | Hepatitis B,Chr... Carcinoma,Hepat... | 21 Years - | Ministry of Health, Malaysia | ||
| Cell Lines From High-Risk Breast Tissue | NCT00032201 | Healthy | 20 Years - 80 Years | National Institutes of Health Clinical Center (CC) | ||
| Isolation and Characterization of Mammary Stem Cells | NCT00340392 | Stem Cells | - | National Institutes of Health Clinical Center (CC) | ||
| The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer | NCT01310062 | Hepatitis B,Chr... Carcinoma,Hepat... | 21 Years - | Ministry of Health, Malaysia | ||
| Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study. | NCT04882475 | Mantle Cell Lym... | 18 Years - 80 Years | Fondazione Italiana Linfomi - ETS | ||
| Sunitinib or Cediranib for Alveolar Soft Part Sarcoma | NCT01391962 | Sarcoma, Alveol... | Cediranib Sunitinib | 16 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion | NCT01256801 | Breast Neoplasm... Neoplasm Metast... Gene Expression... Immunotherapy | cytokine | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | |
| Gene Expression Profile of Breast Cancer Samples After Vitamin D Supplementation | NCT00926315 | Breast Neoplasm... Postmenopausal ... | calcitriol Calcitriol | 40 Years - 70 Years | University of Sao Paulo General Hospital | |
| Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas | NCT04285749 | Malignant Melan... | Fluvastatin RNA-sequencing Gene expression... | 18 Years - 99 Years | Case Comprehensive Cancer Center | |
| Validation of a Molecular Prognostic Test for Eye Melanoma | NCT00406120 | Uveal Neoplasms Choroid Neoplas... Iris Neoplasms | Fine needle asp... | - | Washington University School of Medicine | |
| Translational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell Lymphoma | NCT05318391 | Lymphoma, Large... Gene Expression... | Gene expression... | 18 Years - | Shanghai Zhongshan Hospital | |
| Cell Lines From High-Risk Breast Tissue | NCT00032201 | Healthy | 20 Years - 80 Years | National Institutes of Health Clinical Center (CC) | ||
| UCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell Lymphomas | NCT00082017 | Lymphoma, Large... Lymphoma, T-Cel... | UCN-01 (7-hydro... | 12 Years - | National Institutes of Health Clinical Center (CC) | |
| Validation of 70-gene MammaPrint Profile in Japanese Population | NCT00904566 | Breast Cancer | 29 Years - 70 Years | Agendia | ||
| Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy | NCT01198301 | Breast Neoplasm... Neoplasm Metast... | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | ||
| Validation of a Molecular Prognostic Test for Eye Melanoma | NCT00406120 | Uveal Neoplasms Choroid Neoplas... Iris Neoplasms | Fine needle asp... | - | Washington University School of Medicine | |
| Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy | NCT01198301 | Breast Neoplasm... Neoplasm Metast... | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | ||
| Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM) | NCT01109407 | Smoldering Myel... Monoclonal Gamm... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Cell Lines From High-Risk Breast Tissue | NCT00032201 | Healthy | 20 Years - 80 Years | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
